You are here: Industry Insights > mRNA vaccine

News List

Pfizer-BioNTech COVID-19 vaccine may create set of firsts for pharma sector: GlobalData expresspharma
November 23, 2020
In modern history, no vaccine has ever been considered as essential to restoring normality to our way of life as these first mRNA vaccines, says analyst.
COVID-19 is benefiting contract manufacturing services, suggest reports europeanpharmaceuticalreview
November 19, 2020
Reports have found that the COVID-19 pandemic is providing new opportunities for contract and development manufacturing organisations (CDMOs).
Moderna announces supply agreement with the Ministry of Public Health to supply Qatar with mRNA vaccine against COVID-19 (mRNA-1273) worldpharmanews
October 28, 2020
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273 ..
Canada's Prime Minister, Justin Trudeau, Announced Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19 prnewswire
October 26, 2020
Precision Nanosystems, Inc. (PNI), a global leader in technologies and solutions in genetic medicine, announced that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and ...
Moderna completes enrollment of Phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273) worldpharmanews
October 23, 2020
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that it has completed enrollment of 30,000 participants for the Phase 3 COVE...
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies worldpharmanews
October 16, 2020
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced the preclinical results for MRT5500, a mRNA-based vaccine candidate against SARS-CoV-2, the virus that...
mRNA vaccines the most promising among emerging COVID-19 vaccines: Poll pharmaceutical-technology
August 12, 2020
Vaccination is being considered as the only way the coronavirus pandemic can be controlled, although a highly effective vaccine is not expected to be available in less than a year.
Moderna Announces Start of Phase 3 COVE Study of mRNA Vaccine against COVID-19 americanpharmaceuticalreview
July 28, 2020
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
Sanofi and Translate Bio Expand Vaccine Collaboration contractpharma
June 28, 2020
To develop mRNA vaccines across all infectious disease areas in a deal potentially worth up to $1.9 billion.
Sanofi and Translate Bio team up to develop mRNA vaccines pharmaceutical-technology
June 24, 2020
Sanofi vaccines business unit Sanofi Pasteur has expanded its existing 2018 partnership with messenger RNA (mRNA) therapeutics firm Translate Bio for the development of mRNA vaccines against various infectious diseases.

Previous page 1 2 3 4 5 Next page